Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program

Chang Rung Chen, Yibin Kang, Joan Massagué

Research output: Contribution to journalArticlepeer-review

264 Scopus citations

Abstract

Loss of growth inhibitory responses to the cytokine transforming growth factor β (tgf-β) in cancer cells may result from mutational inactivation of Tgf-β receptors or their signal transducers, the Smad transcription factors. In breast cancer, however, loss of Tgf-β growth inhibition often occurs without a loss of these signaling components. A genome-wide analysis of rapid Tgf-β gene responses in Mcf-1oa human mammary epithelial cells and Mda-mb-231 breast cancer cells shows that c-myc repression, a response that is key to the Tgf-β program of cell cycle arrest, is selectively lost in the cancer cell line. Transformation of Mcf-1oa cells with c-ha-ras and c-erbb2 oncogenes also led to a selective loss of c-myc repression and cell cycle arrest response. Tgf-β stimulation of epithelial cells rapidly induces the formation of a Smad complex that specifically recognizes a Tgf-β inhibitory element in the c-myc promoter. Formation of this complex is deficient in the oncogenically transformed breast cells. These results suggest that a Smad complex that specifically mediates c-myc repression is a target of oncogenic signals in breast cancer.

Original languageEnglish (US)
Pages (from-to)992-999
Number of pages8
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number3
DOIs
StatePublished - Jan 30 2001
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General

Fingerprint Dive into the research topics of 'Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program'. Together they form a unique fingerprint.

Cite this